50-10-2
Chemical Structure
Oxyphenonium bromide
- CAS No.: 50-10-2
- Formula:C21H34BrNO3
- Molecular Weight:428.40
IUPAC Name: 2-(2-cyclohexyl-2-hydroxy-2-phenylacetoxy)-N,N-diethyl-N-methylethan-1-aminium bromide
InChIKey: UKLQXHUGTKWPSR-UHFFFAOYSA-M
SMILES: O=C(OCC[N+](CC)(CC)C)C(O)(C1CCCCC1)C2=CC=CC=C2.[Br-]
Biological Activity: Oxyphenonium bromide is an orally effective competitive muscarinic acetylcholine receptor (mAChR) antagonist. Oxyphenonium bromide competitively binds to and blocks mAChR, thereby inhibiting the parasympathetic pathway. By inhibiting CHRM4, Oxyphenonium bromide increases cAMP levels and activates the CREB transcriptional program, thereby promoting erythroid progenitor cell expansion. Oxyphenonium bromide can be used in research on asthma, anemia, and gastric ulcers[1][2][3][4][5][6][7].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Oxyphenonium bromide | 99.39% | Oxyphenonium bromide is an orally effective competitive muscarinic acetylcholine receptor (mAChR) antagonist. Oxyphenonium bromide competitively binds to and blocks mAChR, thereby inhibiting the parasympathetic pathway. By inhibiting CHRM4, Oxyphenonium bromide increases cAMP levels and activates the CREB transcriptional program, thereby promoting erythroid progenitor cell expansion. Oxyphenonium bromide can be used in research on asthma, anemia, and gastric ulcers. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oxyphenonium bromide (Standard) | ≥98% | Oxyphenonium bromide Standard is the analytical standard of Oxyphenonium bromide (HY-B1719A). This product is intended for research and analytical applications. Oxyphenonium bromide is an orally effective competitive muscarinic acetylcholine receptor (mAChR) antagonist. Oxyphenonium bromide competitively binds to and blocks mAChR, thereby inhibiting the parasympathetic pathway. By inhibiting CHRM4, Oxyphenonium bromide increases cAMP levels and activates the CREB transcriptional program, thereby promoting erythroid progenitor cell expansion. Oxyphenonium bromide can be used in research on asthma, anemia, and gastric ulcers. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Koëter GH, et al. Protective effect of oral oxyphenonium bromide, terbutaline and theophylline against the bronchial obstructive effects of inhaled histamine, acetylcholine and propranolol. European journal of clinical pharmacology. 1984;26(4):435-41. [Content Brief]
- [2]. Trivedi G, et al. Muscarinic acetylcholine receptor regulates self-renewal of early erythroid progenitors. Science translational medicine. 2019 Sep 25;11(511):eaaw3781.
- [3]. Gebauer L, et al. Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3. Journal of medicinal chemistry. 2023 Dec 14;66(23):15990-16001.
- [4]. Ramachandran BV, et al. The Effect of Atropine, Histamine Liberators and Antihistamines on the Absorption of DF32P by Mice, Rats and Guinea Pigs. Acta Pharmacol Toxicol. 1965;23:145-155.
- [5]. Pastukhov IuF. Role of cholinergic elements of the ascending reticular activating system in blocking of the adrenergic electroencephalographic activation reaction by cholinolytics. Bull Exp Biol Med. 1967;64(6):1314-1317.
- [6]. Stabt JL, et al. Differential and Cooperative Effects of TNFα, IL-1β, and IFNγ on Human Conjunctival Epithelial Cell Receptor Expression and Chemokine Release. Invest Ophthalmol Vis Sci. 2003;44:2010-2015.
- [7]. Denisov AB, et al. Use of the new muscarinic cholinolytic KG-62 to correct the course of experimental gastric ulcer. Bull Exp Biol Med. 1991;112:929-933.
